Status:
RECRUITING
A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
Zhejiang University
Shaoxing Central Hospital
Conditions:
Crohn Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Crohn's disease (CD) is a chronic, nonspecific inflammatory disease that can affect the entire digestive tract. It is difficult to cure and often relapses, causing long-term suffering for patients. Th...
Eligibility Criteria
Inclusion
- Patients diagnosed with Crohn's disease according to the 2018 diagnostic criteria established by the Inflammatory Bowel Disease Group of the Chinese Medical Association's Gastroenterology Branch;
- Patients aged between 18 and 75 years;
- Patients with a score of 5-14 on the GAD-7 (indicative of mild to moderate anxiety) or a score of 5-14 on the PHQ-9 (indicative of mild to moderate depression);
- Patients who understand and agree to comply with the study requirements and have signed informed consent;
- Patients who are able to read and access the internet, either independently or with assistance from a family member, and are capable of using WeChat and mobile applications;
- Patients who are able to complete all course trainings and/or follow-up procedures.
Exclusion
- Individuals with a history or current diagnosis of psychiatric illness or cognitive impairment, or those currently taking psychiatric medications; Individuals working in the field of psychology, or those who have previously studied or are currently studying positive psychology;
- Individuals with concurrent other intestinal diseases or malignancies;
- Individuals with severe primary diseases of the cardiovascular, cerebrovascular, hepatic, or renal systems.
- Withdrawal Criteria:
- Patients lost to follow-up due to withdrawal or other reasons during the intervention period;
- Patients who develop severe complications or experience significant changes in their condition that prevent them from continuing the study.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06939712
Start Date
May 1 2025
End Date
April 1 2026
Last Update
July 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Hangzhou, Zhejiang, China, 310009